Evaluation of prophylactic efficacy of silymarin in CC14-induced hepatotoxicity.
D000410:Alanine Transaminase / Q000097:blood; D000438:Alcohols / Q000627:therapeutic use; D000633:Aminopyrine N-Demethylase / Q000378:metabolism; D000818:Animals; D001663:Bilirubin / Q000097:blood; D002252:Carbon Tetrachloride Poisoning / Q000097:blood / Q000201:enzymology / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D056486:Chemical and Drug Induced Liver Injury / Q000201:enzymology / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D005260:Female; D005419:Flavonoids / Q000008:administration & dosage / Q000627:therapeutic use*; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism / Q000473:pathology; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism; D010919:Placebos; D051381:Rats; D014280:Triglycerides / Q000378:metabolism
D000438:Alcohols; D005419:Flavonoids; D010919:Placebos; D014280:Triglycerides; D003577:Cytochrome P-450 Enzyme System; D000633:Aminopyrine N-Demethylase; D000410:Alanine Transaminase; D001663:Bilirubin